Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
27 December 2024 - 8:29AM
Edgar (US Regulatory)
EXHIBIT 99.1
JOINT FILING AGREEMENT
We, the undersigned, hereby express our agreement that the attached Schedule 13G (or any amendments thereto) relating to the Common Stock of Mersana Therapeutics, Inc. is filed on behalf of each of us.
Dated: December 26, 2024
Nextech Crossover I SCSp
By:
Nextech Crossover I GP S.à r.l.
its
General Partner
By:
/s/ Ian Charoub
Name: Ian Charoub
Title: Manager
By:
/s/ Costas Constantinides
Name: Costas Constantinides
Title: Manager
Nextech Crossover I GP S.à r.l.
By:
/s/ Ian Charoub
Name: Ian Charoub
Title: Manager
By:
/s/ Costas Constantinides
Name: Costas Constantinides
Title: Manager
/s/ Ian Charoub
Ian Charoub
/s/ Costas Constantinides
Costas Constantinides
/s/ Rocco Sgobbo
Rocco Sgobbo
Mersana Therapeutics (NASDAQ:MRSN)
Historical Stock Chart
From Dec 2024 to Jan 2025
Mersana Therapeutics (NASDAQ:MRSN)
Historical Stock Chart
From Jan 2024 to Jan 2025